STOCK TITAN

Aehr Test Systems Form 144 reveals small 3k-share insider sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Aehr Test Systems (ticker AEHR) has filed a Form 144 indicating a planned sale of 3,000 common shares through Fidelity Brokerage Services on 15 July 2025. The proposed sale represents approximately 0.01 % of the company’s 29,771,410 shares outstanding and carries an aggregate market value of $42,390.

The shares to be sold were acquired via seven separate restricted-stock vesting events between 18 January 2024 and 11 January 2025, totaling exactly the 3,000 shares being registered. The filer reports no other sales in the past three months and affirms awareness of no undisclosed material adverse information about the company, in line with Rule 144 requirements.

Given the small size of the transaction relative to float and its origin from routine equity compensation, the filing is unlikely to be financially material for most investors, but it does add a data point to insider-trading dashboards.

Positive

  • No sales reported in the prior three months, suggesting the filer is not in an ongoing liquidation program.
  • Shares being sold were earned via compensation, implying the transaction is likely personal liquidity rather than negative operational signal.

Negative

  • Insider intends to sell 3,000 shares, which, although small, can be perceived as a mild bearish signal on insider sentiment.

Insights

TL;DR: Insider plans to sell 3,000 AEHR shares (0.01% of float); immaterial impact.

The Form 144 discloses a routine, low-volume insider sale worth roughly $42k. All shares stem from recently vested restricted-stock awards, so the sale appears to be normal liquidity rather than a strategic exit. With fewer than 0.02 days’ average trading volume affected and no additional insider sales in the prior quarter, the event is neutral to valuation. Nonetheless, traders tracking insider sentiment may note the transaction, particularly if similar filings accumulate.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many AEHR shares are being registered for sale under this Form 144?

The filing covers 3,000 common shares.

What is the market value of the shares to be sold?

The aggregate market value is $42,390.

When is the approximate sale date for the AEHR shares?

The filer indicates an approximate sale date of 15 July 2025.

What percentage of Aehr Test Systems’ outstanding shares does the sale represent?

The 3,000 shares equal roughly 0.01 % of the 29,771,410 shares outstanding.

Were any AEHR shares sold by this insider during the last three months?

No. The filing states "Nothing to Report" for sales in the past three months.
Aehr Test Sys

NASDAQ:AEHR

AEHR Rankings

AEHR Latest News

AEHR Latest SEC Filings

AEHR Stock Data

1.03B
28.77M
Semiconductor Equipment & Materials
Instruments for Meas & Testing of Electricity & Elec Signals
Link
United States
FREMONT